ASP Isotopes (NASDAQ:ASPI) Stock Price Up 10.1% – What’s Next?

Shares of ASP Isotopes Inc. (NASDAQ:ASPI) rose 10.1% during trading on Thursday . The company traded as high as $7.32 and last traded at $7.3420. Approximately 1,633,294 shares traded hands during trading, a decline of 68% from the average daily volume of 5,049,644 shares. The stock had previously closed at $6.67.

Analysts Set New Price Targets

Several research analysts recently issued reports on ASPI shares. Weiss Ratings reiterated a “sell (d-)” rating on shares of ASP Isotopes in a research note on Friday, March 27th. Canaccord Genuity Group reaffirmed a “buy” rating and set a $11.00 target price on shares of ASP Isotopes in a research note on Tuesday, April 14th. Two analysts have rated the stock with a Buy rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average price target of $13.00.

ASP Isotopes Trading Up 0.1%

The stock has a market cap of $979.50 million, a PE ratio of -3.74 and a beta of 3.26. The firm has a 50-day moving average price of $5.23 and a 200-day moving average price of $5.90. The company has a debt-to-equity ratio of 0.69, a quick ratio of 4.37 and a current ratio of 4.39.

ASP Isotopes (NASDAQ:ASPI) last announced its quarterly earnings data on Wednesday, May 20th. The company reported ($0.22) EPS for the quarter, beating the consensus estimate of ($0.28) by $0.06. The company had revenue of $8.36 million for the quarter, compared to the consensus estimate of $3.68 million. ASP Isotopes had a negative net margin of 644.40% and a negative return on equity of 112.46%.

Insider Activity

In related news, COO Robert Ainscow sold 22,500 shares of the company’s stock in a transaction that occurred on Thursday, April 16th. The stock was sold at an average price of $5.21, for a total value of $117,225.00. Following the transaction, the chief operating officer directly owned 1,490,317 shares of the company’s stock, valued at approximately $7,764,551.57. This represents a 1.49% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CFO Heather Kiessling sold 23,124 shares of the company’s stock in a transaction that occurred on Wednesday, April 15th. The shares were sold at an average price of $5.48, for a total value of $126,719.52. Following the completion of the transaction, the chief financial officer directly owned 709,376 shares in the company, valued at $3,887,380.48. This trade represents a 3.16% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders have sold a total of 90,704 shares of company stock worth $463,252 over the last 90 days. 14.40% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

Hedge funds have recently modified their holdings of the business. State of Wyoming purchased a new stake in shares of ASP Isotopes during the first quarter valued at $29,000. Quantbot Technologies LP purchased a new position in ASP Isotopes in the 3rd quarter worth about $34,000. BNP Paribas Financial Markets raised its position in ASP Isotopes by 84.9% in the 2nd quarter. BNP Paribas Financial Markets now owns 5,549 shares of the company’s stock worth $41,000 after buying an additional 2,548 shares during the last quarter. Stephens Inc. AR bought a new position in ASP Isotopes during the 1st quarter valued at about $44,000. Finally, Broadhurst Jeffrey B bought a new position in ASP Isotopes during the 1st quarter valued at about $44,000. Hedge funds and other institutional investors own 16.80% of the company’s stock.

About ASP Isotopes

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235. ASP Isotopes Inc was incorporated in 2021 and is headquartered in Washington, District Of Columbia.